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Abstract: Early in the coronavirus-2019 (COVID-19) containment strategy, people with end-stage renal 
disease (ESRD) were identified as extremely clinically vulnerable and subsequently asked to ‘shield’ 
at home where possible. The aim of this study was to investigate how these restrictions and the tran-
sition to an increased reliance on telemedicine within clinical care of people living with kidney disease 
impacted the physical activity (PA), wellbeing and quality of life (QoL) of adults dialysing at home 
(HHD) or receiving in-centre haemodialysis (ICHD) in the UK. Individual semistructured telephone 
interviews were conducted with adults receiving HHD (n = 10) or ICHD (n = 10), were transcribed 
verbatim and, subsequently, thematically analysed. As result of the COVID-19 restrictions, PA, well-
being and QoL of people with ESRD were found to have been hindered. However, widespread sup-
port for the continued use of telemedicine was strongly advocated and promoted independence and 
satisfaction in patient care. These findings highlight the need for more proactive care of people with 
ESRD if asked to shield again, as well as increased awareness of safe and appropriate PA resources to 
help with home-based PA and emotional wellbeing. 
Keywords: quality of life; health behaviour; doctor–patient communication; experience of illness 
and disease; exercise; user experiences; nephrology; internet technology; wellbeing 
 
1. Introduction 
Early in the coronavirus 2019 (COVID-19) global pandemic, people with some pre-
existing medical conditions were identified as having an increased risk. Since chronic kid-
ney disease (CKD) is associated with a greater risk of both inpatient and outpatient pneu-
monia [1] and a 14–16 times higher pneumonia-related mortality rate than the general 
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population [2], it was unsurprising when early reports from a haemodialysis (HD) facility 
in Wuhan reported a much higher infection rate in people with end-stage renal disease 
(ESRD) [3]. Indeed, a meta-analysis of pooled data also revealed a significant association 
between CKD and more severe COVID-19 infection [4] and a much greater mortality rate 
than the general population. Consequently, in the UK people with ESRD receiving dialy-
sis were classified as ‘extremely clinically vulnerable’ in April 2020 and asked to shield at 
home where possible [4]. 
People with ESRD were now experiencing a change to much stricter regulations. Alt-
hough aimed at limiting COVID-19 transmission, these new restrictions reduced social 
contact and physical activity (PA), potentially leading to negative health implications 
[5,6]. However, unlike other clinical groups, fully shielding people with ESRD from 
COVID-19 was not possible, since they require regular, essential renal replacement ther-
apy (dialysis) and clinical monitoring [7]. Travelling to a dialysis facility for lengthy treat-
ments in close proximity to dialysis staff and other people receiving dialysis may also 
engender additional COVID-19 risks, which is of particular concern given the reduced 
immune function of people receiving dialysis [8]. Nonetheless, reducing the frequency of 
dialysis sessions in an attempt to mitigate the risk of COVID-19 transmission would 
greatly increase the risk of cardiovascular events, or death [9]. 
General population data and reports from early in the COVID-19 pandemic high-
lighted that shielding can have a detrimental impact on the mental health and wellbeing 
of older people [6,10], as well as healthy younger adults not shielding but living under 
restrictions to human movement [11]. PA has been identified as a key modifying factor of 
mental health, with data from a multinational study reporting that a negative change in 
exercise behaviour during the initial COVID-19 restrictions was associated with poorer 
mental health and wellbeing [12]. This is of concern, since poor quality of life (QoL) and 
wellbeing were already known to characterise people with CKD and ESRD before 
COVID-19 [13–15], particularly those receiving dialysis [16,17]. Furthermore, QoL and 
wellbeing are reported to be negatively influenced when dialysis is in the form of in-centre 
haemodialysis (ICHD) [18–20]. Indeed, maintenance ICHD is also associated with re-
duced habitual PA, even when patients are relatively healthy [21–23], likely contributing 
to their typically diminished physical function [24]. Any additional impact of shielding 
from COVID-19 on these factors in people receiving dialysis remains to be elucidated. 
An additional consequence of the COVID-19 pandemic was a rapid change in the 
way clinical care was delivered. Specifically, face-to-face contact between clinicians and 
people living with kidney disease was abruptly reduced and replaced by an increased 
reliance on telemedicine and remote clinics [25–27]. This change in practice is likely to 
persist following the COVID-19 pandemic, at least to some extent, in accordance with the 
2019 NHS Long Term Plan [27,28]. It was therefore important to determine the experiences 
of people with ESRD in receipt of this altered care delivery. 
The present study therefore aimed to explore the experiences of the initial COVID-19 
restrictions on PA, wellbeing and QoL in shielding adults with ESRD in the UK receiving 
ICHD or HHD, as well as their experiences of telemedicine. 
2. Materials and Methods 
This study consisted of individual semistructured interviews conducted over the tel-
ephone between 10 June and 10 July 2020. Semistructured interviews provide a rich, per-
sonal narrative of participants’ experiences and rely upon the rapport and relationship 
between researcher and participant. This time period was chosen to correspond with the 
initial COVID-19 containment strategies concerning human movement in the UK and fol-
lowing the reclassification of people with CKD and ESRD as ‘extremely clinically vulner-
able’. The study was designed and conducted in line with Guba and Lincoln’s criteria for 
rigour in qualitative research [29] and reported using the COnsolidated criteria for RE-
porting Qualitative research (COREQ) checklist [30]. 
  




Adults with ESRD currently under the care of the Wessex Kidney Centre and receiv-
ing either ICHD (n = 10; 61.2 ± 8.9 years; 8 males; time on dialysis: 44 ± 58 months) or HHD 
(n = 10; 65.4 ± 11.8 years; 6 males; time on dialysis, 61 ± 46 months) were invited by a 
member of their primary clinical team or the principle researcher (JA) to participate. Fully 
informed verbal consent was obtained prior to participation. Inclusion criteria consisted 
of being ≥ 18 years of age, willing and able to provide consent and being free from any 
psychiatric or neurological diagnosis at the time of interview. Recruitment continued until 
data saturation was reached (i.e., little new data was appearing within interviews and 
concepts were well developed [31]. Several additional interviews were conducted to con-
firm data saturation, totalling 10 in each group. 
2.2. Dialysis Management 
People receiving ICHD must attend three sessions per week, which typically last 3–5 h 
depending on the time required to achieve adequate waste removal and fluid removal. Most 
of these individuals also require patient transport services to assist with travel to and from 
their dialysis unit. The Wessex Kidney Centre HHD programme exclusively uses the 
NxStage® System 1 or 1S dialysis machines (NxStage Medical Inc, Merrimack St. Lawrence, 
MA, USA), with dialysis prescriptions varying between short daily dialysis to alternate day 
nocturnal regimens, utilising dialysate volumes ranging from 20 to 60 L. Dialysis prescrip-
tions are adjusted to achieve a standardised weekly adequacy (2.4 Kt∙V-1), with flexibility 
given to individuals with a significant residual urine volume. 
2.3. Telemedicine 
Before the COVID-19 pandemic, people with ESRD attended routine quarterly face-
to-face clinics with their renal consultant. For those on ICHD, this usually involved at-
tending the dialysis centre and conducting a consultation at the bedside. As a result of 
COVID-19 restrictions, it was necessary to undertake these routine reviews by telephone 
rather than face-to-face. For people with additional comorbidities (e.g., diabetes, cardiac 
or respiratory conditions), additional telephone clinics were also required with other spe-
cialties. For people receiving HHD (but not those on ICHD), the Wessex Kidney Centre 
HHD introduced a digital remote monitoring platform (MyRenalCare®-
https://www.myrenalcare.com/) before the COVID-19 restrictions were implemented. 
This system was developed by Ardia Digital Health Ltd.® in collaboration with the Wessex 
Kidney Centre. It is a purpose-built, integrated telehealth platform for people with ESRD 
and their clinicians, which aims to help people living with kidney disease take ownership 
of recording clinical and technical information about their HHD sessions and patient-re-
ported outcome measures. This was continued during the COVID-19 restrictions. 
2.4. Data Collection 
Individual semistructured telephone interviews were conducted by JA. Given that 
this population were still largely isolating at home due to the initial UK COVID-19 re-
strictions, face-to-face interviews were not permitted. Through initial Patient and Public 
Involvement with people receiving dialysis and their clinicians, as well as previous at-
tempts to use alternative technology for research with this cohort, a telephone call was 
deemed more feasible than video conferencing software. Participants were asked to be at 
home and ensure they were ‘comfortable’ with their surroundings. For people receiving 
ICHD, interviews were conducted on a non-dialysis day. Since most people receiving 
HHD dialyse six days per week, conducting interviews on non-dialysis days was not al-
ways possible and thus they were conducted at a different time from their dialysis session, 
thereby minimising any acute impact of the dialysis session. 
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An interview guide comprising 15 open-ended questions was developed through a 
review of the literature and informal discussions with potential participants and the re-
search design team. Specifically, the interview guide sought to explore aspects of the par-
ticipants’ PA, wellbeing and QoL during this period, as well as their experiences of the 
increased use of telemedicine within their clinical care. Participants were informed that 
the researcher conducting the interviews was not part of their clinical care team and was 
interested in understanding the impact of the COVID-19 restrictions on all aspects of their 
life, for example: “How are you feeling about the current situation and the changes caused 
by the COVID-19 outbreak?” and “Please can you tell me about your current experiences 
with medical appointments?” During the interviews the topic guide was used flexibly, 
with prompts and probes used to encourage participants to expand and elaborate on top-
ics when needed and to include any additional information they felt necessary. The inter-
views ranged from 22 to 75 min (median length: 30 min) and were concluded when each 
participant felt that they had nothing further to add. The interviews were audio recorded 
and then transcribed verbatim. All audio recordings/transcripts were only available to 
members of the research team and all transcripts were anonymised immediately. 
2.5. Data Analysis 
Transcripts were analysed using NVivo 12 software package (QSR International, 
Doncaster, Australia) and coding and thematic analysis undertaken using a systematic 
approach [32]. An abductive approach was taken to combine codes to generate families of 
ideas or similar over-arching themes. First, a code manual was developed to organise sim-
ilar ideas and relate texts to assist with the interpretation of the data. The second stage 
involved summarising the data individually and identifying any initial themes (con-
ducted by J.A., D.J.B. and Z.L.S.). Third, the initial themes were revisited, and codes ap-
plied, before being regrouped into more definite groups. Fourth, the final codes and 
themes were corroborated (conducted by J.A. and D.J.B.). Finally, the results were dis-
cussed with several other researchers within the team so that internal thinking processes 
were made explicit, ideas clarified, and new insights obtained. 
3. Results 
Twenty adults with ESRD (10 receiving HHD and 10 receiving ICHD) were enrolled 
in this study. Throughout the interviews in this study, it became clear that people ex-
pressed the impact of the COVID-19 restrictions through how aspects of their lives had 
changed or indeed remained similar to before the pandemic. Within this, the dimensions 
of PA, wellbeing and QoL, and medical care were discussed, and several key themes iden-
tified (Figure 1). 




Figure 1. Summary of the themes identified during thematic analysis. These denote the key the-
matic areas discussed as having been changed or not changed as a result of the COVID-19 re-
strictions. N.B. PA, physical activity. 
3.1. HHD Group 
3.1.1. Dimension: PA 
Maintained PA 
Some of the participants described how their levels of PA have either remained the 
same or even improved. Indeed, one individual stated that their PA did not change, “be-
cause we have largely gone about our normal business and near here there are walks 
around here that you can do without meeting anyone anyway”. Similarly, another stated: 
“I go for quite long walks with the dog. Again, it’s only in the fields and stuff, I don’t go 
to any built-up areas, but I am following the guidelines to protect myself, but I am also 
kind of stretching them a bit to suit myself”. 
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Changes in PA 
With regard to PA, participants described two changes as a result of the COVID-19 
restrictions, with the first being changes in frequency of PA, where individuals described 
a notable change in the amount of time spent being physical active compared to before 
the COVID-19 restrictions. One participant said: “Oh, well yes they [PA levels] have gone 
down quite a lot obviously”. On the contrary, one participant described an increase in the 
amount of PA they were undertaking, due to the impact of working from home and the 
extra time this gave, saying: “I think, they have actually gone up, randomly. I really took 
the opportunity because I enjoy my running, so I have really taken the opportunity to get 
back into that and yes, we have been cycling regularly”, which suggests not all individuals 
were strictly shielding. 
The second change was in the modality of PA, which saw individuals changing their 
approach to PA as a result of the restrictions, including gardening or indoor alternative to 
exercise. For example, one participant said “Yes, so I started doing P.E. [Physical Educa-
tion] with Joe Wicks and I started doing that Monday to Friday”. Another participant said: 
“We are lucky we have a garden, so we have been doing gardening. We have had plants 
delivered and made use of the garden and working in the garden”. 
3.1.2. Dimension: Wellbeing and QoL 
Aspects Maintained 
Participants in the HHD group described four areas which they felt had remained 
constant from prior to the COVID-19 pandemic and associated restrictions in relation to 
their wellbeing and QoL. The first of these areas related to the participants’ employment, 
with a number of individuals stating that they felt the support received from colleagues 
had remained consistent. For example, one participant said, “one of the assistant manag-
ers phoned me later and then I felt supported”. A second area described was the stability 
in their psychological wellbeing, which had remained constant throughout COVID-19. 
For example, one participant said: “Predominantly over the last three years I have been 
having counselling [to support my wellbeing] and I think yes, COVID-19 was in there [so 
my psychological wellbeing has remained constant]”. Thirdly, participants described 
their renal treatment and how their exposure to a chronic condition prepared them for the 
social requirements of COVID-19, with one participant stating: “We had to alter our lives 
so dramatically because of dialysis, which is a daily event … in a way, we had a prelude 
to losing freedom”. Finally, participants described their experience as having no change, 
with many expressing the lack of effect as a result of the COVID-19 restrictions. For ex-
ample, when asked what had changed, one participant stated: “Well not a lot really be-
cause we didn’t used to socialise that much, only to see the family”. Furthermore, another 
said: “We can be pretty productive, and I don’t really feel as though we have suffered 
particularly”. 
Aspects Changed 
Participants described four areas they felt had changed in relation to their wellbeing 
and QoL as a result of the COVID-19 restrictions. The first of these related to their behav-
ioural changes, as they had to adjust to adhere to social distancing guidelines. For this 
group of extremely clinically vulnerable individuals, this mandated complete isolation if 
possible, including from exercising outdoors. One individual noted: “Yes, well obviously, 
it affected what I do when I go out. I have been out a few times and if I have gone out at 
all it has been very early in the day when there are very few people about, and I do tend 
to give people a very large margin when I do go out walking”. Another participant de-
scribed changes in communication methods saying: “It has changed, in the way that we 
normally speak and see people. We tend to have a lot of people coming around to see us 
for coffee, not parties or anything but just general, so that has been quite different, but we 
have done some stuff on Zoom and texting and stuff like that”. 
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A second area of change was described as feelings of independence and captured the 
emotional responses felt by participants through changes caused by COVID-19. When 
asked to describe how they felt, one participant expressed upset: “In the point that none 
of us can live our lives the way we would like to”. The third area of change was described 
as the emotional impact of the COVID-19 restrictions, where participants felt left behind 
or disappointed due to their vulnerability to COVID-19, with one participant saying “I 
was a bit disappointed to receive it [the letter informing them of their vulnerability status], 
but that is something which is just personal disappointment that I wish I wasn’t that much 
more vulnerable than anyone else”. Moreover, another participant stated that: “I was very 
tentative and didn’t really know what to expect and I felt like the rest of the world had 
already done it [left the house] and I was the last person to do it, if you like”. The final 
area of change was described as an increased concern, including concerns for job security, 
obtaining essential supplies and feeling safe to leave the house. When probed, participants 
expressed their “only worry was with work, was I going to have a job at the end of this 
isolation and the end of the shielding”, “That was really difficult to begin with, we really 
struggled with that [obtaining essential supplies] to begin with because we couldn’t get a 
supermarket slot” and “I would be concerned about going into hospital because I’ve heard 
a few stories of people going in and actually catching [COVID-19] it in hospital”. 
3.1.3. Dimension: Medical Care 
Aspects that Have Remained the Same 
When individuals described their medical care during the initial COVID-19 re-
strictions, two distinct unchanged experiences were noted. First, confidence in renal staff, 
with individuals describing their maintained confidence and outspoken praise for their 
clinical teams. For example, when asked about any changes to their medical care as a re-
sult of COVID-19 and the restrictions put in place, one participant said: “No, none at all, 
it has all been as it always has been. I am very applauding and grateful for that because at 
no stage was there any feelings of fear or anxiousness”. 
The second unchanged experience was the support from the HHD team, with indi-
viduals describing a constant and proactive approach from the HHD team to ensure their 
welfare. For example, one participant said: “Well actually, a bit more support this time. 
Since the COVID-19 lockdown, I have had more support than before. I mean, before the 
support was always there available but now it is more proactive where I actually get 
called”. 
Aspects that Have Changed 
Participants described two areas where the COVID-19 restrictions have resulted in 
change in their medical care. The first of these related to communication difficulties, with 
some individuals describing incidents where communication was lacking, with one indi-
vidual saying “Yes, I mean, to be honest with you, that has been the [most] frustrating 
thing of all, is not knowing what the results were and being able to actually talk them 
through”. One participant also described how the proactive response of the HHD team 
may have been unnecessary: “For a while after a few weeks ago, I was having weekly 
phone calls and I almost found them unnecessary, because I didn’t need them before, my 
situation hasn’t changed in the fact that I am a home patient so I knew that if I had an 
issue, there would be someone there for me”. 
The second change related to concerns with future care where individuals expressed 
their concerns regarding future transplants and concerns returning to clinical environ-
ments: “Yeah, we are concerned that if it’s going to interrupt the prospect of transplants 
with the people and operations and all the rest of it so that concerns me”. 
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3.1.4. Dimension: Experience of Telemedicine 
Throughout these discussions, participants described two areas relating to the use of 
telemedicine during the COVID-19 restrictions. The first of these was support for telemed-
icine, where individuals expressed their support for the use of telemedicine and described 
positive experiences they have had utilising remote medicine within their clinical care: 
“Oh, I would be more than happy actually [to continue remote clinics]. It saves me trav-
elling a long way. Absolutely fine, I would prefer [to continue remote clinics], I think”. 
However, individuals generally expressed their opinion that the use of video conferencing 
would be more beneficial than a telephone call, as it allows the use of nonverbal commu-
nication: “It would be better if you could do it via video link because then you can see the 
other person”. These experiences were for routine care where there is no particular issue, 
and many expressed that should an issue arise, they would rather a face-to-face consulta-
tion: “Yes, that would be fine to say yeah, I mean, obviously, if I did start not feeling well, 
or things, then I would like to see face-to-face but in general, I can’t see a problem with 
that”. 
The second area relating to the use of telemedicine, was concerns about remote med-
icine, where individuals expressed their dislike for the formality of telephone appoint-
ments and the lost elements of nonverbal communication when utilising telemedicine: “I 
probably wouldn’t mind for the next three months when things are still settling or what-
ever, but I honestly don’t think you can beat hands-on seeing somebody”. 
3.2. ICHD Group 
3.2.1. Dimension: PA 
Changes in PA 
Within the changes in PA, two areas were described. These two areas were changes 
in frequency and changes in modality. When this topic was discussed, most people fell 
within these areas. One individual discussed their reduction in frequency as “My PA was 
walking, and, in the house, there isn’t a lot of walking that you can do. They say to run up 
and down the stairs, but I can barely make it upstairs once let alone run up them”. Another 
described a change in modality as “Well there is a strange thing called housework and 
that has been receiving more attention than in the past, shall we say”. 
3.2.2. Dimension: Wellbeing and QoL 
Aspects Maintained 
During the discussions, all participants expressed two aspects of wellbeing and QoL 
that have remained the same during the COVID-19 pandemic. The first aspect is described 
as that of no change where many individuals described the lack of changes to their lives 
compared to the time before the pandemic. For example, two individuals said: “I can’t say 
that it has affected me a great deal” and “To be perfectly honest, it [COVID-19 restrictions] 
has changed our lives very little”. Secondly, many people reported that they were accept-
ing of vulnerability and did not seem to be affected by their addition to the clinically ex-
tremely vulnerable list: “No, I don’t think it affected me. If something is going to happen, 
it is going to happen, isn’t it?” 
Aspects Changed 
When discussing aspects that have changed, five areas that have changed over this 
period were identified. The first of these being an impaired wellbeing, where individuals 
have described how the changes made during the COVID-19 pandemic have affected their 
lives: “It has upset my complete wellbeing. I was in a routine for so long and then all of a 
sudden it changed”. 
A second aspect that had changed was social interactions, with all people inter-
viewed who were receiving ICHD describing a reduction in their social interactions, but 
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an uptake of social media use. One individual said “Oh, unbelievably so. I was talking to 
my partner, I would say 85% of the time and conversations get a bit strained after a while, 
there is only so much we can talk about”. 
Issues with societal restrictions were also noted, with individuals describing how 
they were out of touch with social distancing and societal requirements due to their time 
shielding: “I went into the main door and I walked straight to where we normally go to 
speak to a waiter and he said sorry madam, back to the cross on the floor because I am not 
used to it”. 
Concern for the future was also identified, with many describing their worry and 
anxiousness for what is to come: “A bit scared for the future quite honestly, because I 
don’t think that’s the last we are going to see of it. I have a feeling that once the winter 
sets in, it will be back”. 
The final aspect is one of a positive experience where individuals have identified 
communal support whether this be from family, neighbours, friends or local councils to 
assist them throughout the pandemic: “The council here, have been very good. They have 
tried to send us a food parcel and all of that”. 
3.2.3. Dimension: Medical Care 
Aspects that Have Remained the Same 
When discussing their medical care, two themes were identified to have remained 
stable over this time. The first of these was administrative issues, which involved the dif-
ficulties with dialysis sessions, test results and facilitation of routine care: “Well obviously, 
they have moved me from QA [Queen Alexandra Hospital, Portsmouth] to Havant, and 
that was just a total nightmare for the first 4 to 6 weeks, it was horrendous” and another 
saying “Well, they come too late to get you to your appointment and they don’t take into 
account the fact that they bring you in late and they expect you to be ready on time”. 
The second of these is communication difficulties with staff, where many issues and 
difficulties were caused by communication, or lack thereof with members of staff: “There 
has been no follow-up, no how are you getting on? No, this that or the other”. 
Aspects that Have Changed 
When discussing their medical care throughout the COVID-19 pandemic, three 
changes experienced were identified. The first of these is that some of individuals have 
reported to look forward to dialysis as it acts a break from the lockdown and the re-
strictions and provides social interactions: “But I mean as far as I am concerned, in terms 
of the pandemic, it was a bit of a release to be honest of you being able to get out of the 
house three times a week to go to the dialysis and see other people”. 
The second of these is the confidence in renal staff, where individuals have described 
the confidence that they feel from the nursing staff taking care of them: “Yes. Yes, as I said, 
they are really good there, so they all talk to you and if you feel down or you want to talk 
to someone, they are there. You know, that we all have a laugh and that”. 
The final experience identified is surrounding concerns for attending hospital, where 
many individuals have expressed their wariness of attending hospitals for routine ap-
pointments and even for dialysis: “Yes. I felt more at risk, obviously even though I was 
putting on PPE to go into a taxi, so I felt more at risk doing that and going to the dialysis 
centre than because of the environment”. 
3.2.4. Dimension: Experience of Telemedicine 
When discussing the experience of telemedicine two themes were identified. The ma-
jority of the responses were in support for remote clinics, describing the benefit of reduced 
travel and waiting time and not having to attend the hospital for a quick chat with one 
describing it as “Providing the physicians are up to speed with what is going on in your 
life and your records, I think it is an extremely good way of doing it. It cuts down on travel 
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time and their time”. Certain points were raised however in support of face-to-face ap-
pointments, when the patient or clinician identified a problem that they would like to 
discuss. 
The second theme was regarding the dislike of remote clinics, where individuals de-
scribed how they enjoyed the conversation and took comfort in seeing the clinician taking 
notes and providing an action plan in person. For example, when questioned, an individ-
ual said: “Yes, because I think if you talk to someone face-to-face about your problems 
and what you have got going on, I find that they understand and listen more. If you do it 
over the phone, I don’t know, I just feel like, I know they are good and they do take stuff 
on board but, you know, it’s just like a phone call, you know what I mean”. 
4. Discussion 
The primary aim of this study was to explore the impact of initial COVID-19 shield-
ing restrictions to human movement (March–July 2020) on PA, wellbeing and QoL of ‘ex-
tremely clinically vulnerable’ adults with ESRD in the UK who were receiving ICHD or 
HHD. Furthermore, this study sought to ascertain their experiences of an increased reli-
ance on telemedicine within clinical care. The principle findings were that, irrespective of 
dialysis modality (HHD or ICHD), PA, QoL and wellbeing, as well as medical care, were 
all impacted during this period. All individuals receiving ICHD reported negative conse-
quences to their PA, QoL, wellbeing and medical care, whereas conversely, those receiv-
ing HHD primarily reported feelings of little change or a positive impact on their day-to-
day life. However, a positive observation was the widespread support for the use of tele-
medicine within clinical care, regardless of whether people were attending ICHD or dia-
lysing at home. 
Early in the COVID-19 global pandemic it became apparent that, although shielding 
aimed to reduce the health risks posed to more vulnerable individuals, it also had the 
potential to bring about a number of negative physical and psychosocial health conse-
quences. For example, a major immediate consequence of the restrictions to human move-
ment was a reduced ability for many people to perform their typical frequency and pre-
ferred modality of PA [12], particularly in those advised to shield from the virus [6]. In 
the present study, all people receiving ICHD, with the exception of one individual who 
chose to act against recommendations, described a significant reduction in the frequency 
of their PA as a result of their shielding from COVID-19, as well as many of the HHD 
group. 
Reduced PA as a result of the COVID-19 related restrictions is particularly concern-
ing given that people with ESRD were generally engaging in less PA than recommended 
prior to these constraints, with a previous trial in the United States reporting that 56% of 
their cohort of people with ESRD were only active once or less per week [33]. This negative 
change in PA behaviour during the COVID-19 pandemic is, however, in line with other 
groups with long-term health conditions. For example, a recent investigation in people 
with cystic fibrosis reported lower PA in half of the participants surveyed during the 
COVID-19 lockdown in Switzerland with reasons for this including training facility clo-
sures, lack of motivation, and cancelled supervised training [34]. This is concerning, given 
the associated detrimental physical and psychological health effects of inactivity, which 
may well have greater implications in people with chronic health conditions. Indeed, only 
a few days of inactivity can induce skeletal muscle loss, reduce aerobic fitness (an im-
portant health marker) and worsen insulin resistance [35]. Specifically, in adults with well-
controlled type 2 diabetes mellitus, the COVID-19 lockdown induced metabolic worsen-
ing in approximately a quarter of their sample [36,37]. Importantly, type 2 diabetes melli-
tus is a frequent comorbidity in people with renal failure [38,39], with an estimated 30% 
of people with diabetes in the UK having CKD stage 3–5 [40] and is the most common 
cause of ESRD in most countries [41]. 
Prior to the COVID-19 pandemic, wellbeing and QoL were often reduced in people 
with ESRD [42,43], especially when receiving dialysis [44]. Since physical inactivity was 
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already associated with greater levels of anxiety and depression in people with ESRD re-
ceiving ICHD pre-COVID-19 [21], it is conceivable that this may have been further im-
pacted whilst shielding from the virus. Indeed, a recent multicountry analysis showed a 
negative change in PA behaviour during initial lockdown restrictions to be associated 
with poorer mental health and wellbeing in the general population [12], with additional 
UK-based data reporting higher levels of PA during this time to be associated with better 
mental health [45,46]. The association between PA and wellbeing and QoL is well docu-
mented, with many reporting better health-related QoL and perceptions of wellbeing in 
people who are more physically active [33,47–49]. A recent study in 18–78 year olds dur-
ing nationwide lockdown restrictions in Spain noted increased levels of anxiety and de-
pression during the COVID-19 pandemic [11]. Furthermore, greater levels of anxiety have 
also been reported in people with cancer during the COVID-19 restrictions [50,51], as well 
as individuals with rheumatological conditions reporting a worsening of their health-re-
lated QoL [52]. 
In the present study, it was not only the volume but also the type of PA that was 
impacted in adults with ESRD, with all interviewed participants from both groups report-
ing that this had changed. Those who has previously undertaken frequent trail and group 
walking, cycling and personal training type activities reported a shift to walking alone, 
indoors and outdoors, and an increase in home-based activities, such as housework 
and/or gardening. In contrast to recent findings in people with cystic fibrosis [34] and 
general population data [12], only one of the participants in the present study reported 
using social media or digital health technology to help them be physically active during 
this period. Interestingly, several participants did express a desire to participate in this 
type of activity, however, they stated that they did not know where to begin. 
Although general recommendations regarding alternative home-based PA during 
COVID-19 restrictions have been shared for the general population [53,54], and various 
generic online exercise platforms are available, the present findings highlight the need for 
safe methods which are more specifically tailored to allow people with renal disease to 
exercise at home [55]. Promisingly, following these interviews, Kidney Beam 
(https://beamfeelgood.com/kidney-disease) has been developed; an online platform 
which aims to help with PA and emotional wellbeing in people with kidney disease that 
is free for people in the UK until 30 November 2021. 
In addition to PA, other contributors to reduced wellbeing and QoL were reported 
in our cohort of shielding adults with ESRD. Many described reduced social interactions, 
with this being particularly apparent in people receiving HHD compared to those attend-
ing for ICHD. Although attending dialysis has been highlighted as an increased risk factor 
for contracting COVID-19, partly due to the large groupings of people within a relatively 
small clinical area [3], our cohort of people receiving ICHD during this time actually ex-
pressed an eagerness to attend their dialysis sessions as it provided them with a break 
from their enforced isolation and, with this, an opportunity to speak to other people. This 
was highlighted as being particularly important with individuals from both of our study 
groups reporting increasingly stressed familial relationships during this time. These find-
ings support recent evidence from Sousa et al. [56], who documented increased stress and 
anxiety surrounding the COVID-19 virus in an ICHD population in Portugal, with people 
often suffering in isolation. Similar experiences were captured in the present study, with 
many reporting feeling that they had lost their freedom and independence. This was par-
ticularly so in people receiving HHD, likely due to their previously increased independ-
ence. 
The secondary focus of this study was to capture the experiences of adults receiving 
ICHD and HHD with regards to changes to their clinical care and the necessary increased 
reliance on telemedicine. More specifically, there was a need to move routine medical care 
to virtual delivery and for some ICHD dialysis sessions to change location. A primary 
positive finding was that people receiving HHD during this time period felt that they re-
ceived constant proactive support, in the form of consistent and regular phone calls. Since 
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the treatment of people receiving HHD is largely independent and requires minimal day-
to-day input from clinicians, a largely unchanged treatment experience was noted in this 
group, despite reduced face-to-face contact with their renal clinician. People dialysing at 
home also reported few issues or concerns with regards to their medical care. However, 
the experience of people receiving ICHD was affected to a greater extent. 
The clinical care of people receiving ICHD requires input from dialysis nurses and 
therefore incorporates travelling to a clinical facility three times per week. The ICHD 
group in the present study reported a number of administrative issues and communica-
tion difficulties, which at times resulted in problems with their medical care, such as de-
layed prescriptions, missed clinic appointments and even missed dialysis sessions. Similar 
issues to our cohort in the UK were identified in adults receiving ICHD during a COVID-
19 lockdown in India where specifically, COVID-19 had similar effects on the dialysis in-
frastructure resulting in missed dialysis sessions and appointments and, consequently, a 
negative patient experience [57]. These observations within renal disease are in line with 
a global-survey in health care professionals caring for people with a variety of chronic 
diseases using adapted delivery methods during COVID-19, in which 67% perceived 
moderate-to-severe negative effects on their patients [58]. 
A positive finding in the present study was, however, the experiences with telemed-
icine and an increased use of digital health technologies, which lends support to the NHS 
five-year forward view to use more technology within routine care [59]. More recently, 
the Carter report [60] highlighted the need to look at digital solutions as a way to promote 
efficiency within the NHS. Those who dialyse at home within the Wessex Kidney Centre 
were already familiar with MyRenalCare® and were more accustomed to remote medicine 
and feedback than those dialysing in-centre. Generally, individuals in this study sup-
ported the use of remote clinics and telemedicine saying that it was nice to reduce waiting 
and commuting time. This supports recent findings [61], which found a high level of sat-
isfaction with telemedicine when used in an Ear, Nose and Throat (ENT) department 
throughout the COVID-19 restrictions. 
Prior to COVID-19, the use of telemedicine to perform renal clinics was shown to be 
accepted by clinicians with benefits of reduced travel time, more efficient use of staff time, 
and a strong sense of job satisfaction being reported [62], akin to other clinical specialties 
[63–65]. A recent publication by the American Society of Nephrology outlined the expec-
tation for telemedicine to remain within renal medicine in some form following the 
COVID-19 pandemic and associated restrictions [66]. Moreover, a similar study con-
ducted during COVID-19 in renal clinicians also reported widespread support for tele-
medicine, reporting more efficient use of staff time, reduced travel, peace of mind and a 
strong sense of job satisfaction [67]. The initial experience of the participants in this study 
is therefore valuable to help inform what this future clinical management may look like. 
Several participants also had negative experiences with the current use of telemedi-
cine or aspects of it, with some highlighting that they felt that the face-to-face interaction 
with their consultant or medical professional would provide more comfort in the depth 
of care they were receiving. This is in line with findings by Fieux et al. [61], which found 
that clinicians acknowledged a lack of complete medical care caused by reductions in hos-
pital outpatient procedures, within an ENT department. Some of the alternatives sug-
gested by participants in the present study included video conferencing rather than tele-
phone calls, using remote clinics every other appointment or the use of remote clinics 
when there is no concern, with the option of face-to-face when the patient had something 
to discuss, as well as an opt-in mechanism for remote care. The findings from this study 
lend support to the use of remote clinics within the clinical management of people with 
ESRD receiving HHD or ICHD in the future, however, lessons can be learnt from delivery 
during the current pandemic and enhancements made [68,69]. This study also provides 
initial insight into patient feedback of using the MyRenalCare® application which, alt-
hough originally developed for HHD, may have potential use for the monitoring of peo-
ple receiving ICHD, particularly on nondialysis days. Moreover, this study highlights the 
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need for more proactive care if/when people may be asked to shield again and support 
for the implementation of telemedicine in routine care, in line with the NHS forward view 
[59,60] and the NHS Long Term Plan [28]. Finally, the recently developed Kidney Beam 
platform is an example of the implications of digital platforms to promote PA, with this 
study supporting the use of telemedicine to promote independence in patient care. 
The present findings need to be interpreted in the context of several methodological 
considerations. First, it has been acknowledged that the modality may alter the interview 
and, more specifically, the use of telephone interviews for qualitative research is consid-
ered by some to reduce the quality of data obtained [70]. However, this method has been 
used successfully in previous research both during the current pandemic and in previous 
research into QoL of adults with ESRD [71,72]. Nonetheless, the choice of telephones, as 
opposed to online video platforms, was informed by patient and public involvement dur-
ing the trial design. It would, however, be of interest to follow up some of these individ-
uals with face-to-face interviews when social restrictions are not in place. Second, whilst 
the use of semistructured interviews enabled the discussion of a broad range of issues, 
including PA, it is appreciated that PA was not objectively measured. Therefore, further 
research to investigate the PA behaviours of this population using validated accelerome-
ters as we progress through the COVID-19 pandemic and ongoing restrictions to human 
movement is warranted. Finally, longitudinal follow-up of these individuals is important 
to understand any longer-term impact of the COVID-19 pandemic on their PA behaviours, 
QoL and wellbeing, as well as identifying any need for additional rehabilitation. 
5. Conclusions 
In conclusion, this study provides valuable insight into the experiences of shielding 
adults with ESRD, receiving ICHD and HHD in the UK, during the initial COVID-19 re-
strictions. During this period, PA behaviours, wellbeing and QoL, as well as confidence 
in care in the ICHD group, were all negatively affected. The majority of people inter-
viewed had positive experiences of the increased use of telemedicine within their clinical 
care. These findings highlight the need for more proactive care if people are asked to 
shield again, as well as increased awareness of safe and appropriate PA resources to help 
with home-based PA and emotional wellbeing, such as the newly developed Kidney Beam 
platform. 
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